Navigation

benzonatate (Tessalon, Tessalon Perles, Zonatuss)

 

Classes: Antitussives

Dosing and uses of Tessalon, Tessalon Perles (benzonatate)

 

Adult dosage forms and strengths

capsule

  • 100mg
  • 150mg
  • 200mg

 

Cough

100 mg, 150 mg, 200 mg PO q8hr; 600 mg/day maximum

Administration

  • Swallow whole; do not chew

 

Pediatric dosage forms and strengths

capsule

  • 100mg
  • 150mg
  • 200mg

 

<10 years

Safety and efficacy not established

 

>10 years

Cough: 100 mg, 150 mg, 200 mg PO q8hr; 600 mg/day maximum

Administration

  • Swallow whole; do not chew

 

Tessalon, Tessalon Perles (benzonatate) adverse (side) effects

Frequency not defined

Hypersensitivity reaction; bronchospasm, laryngospasm, cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule or perle

Chest numbness

Chilly sensation

Confusion

Constipation

Dizziness

GI upset

Hallucinations

Headache

Nasal congestion

Nausea

Pruritus

Sedation

Skin eruptions

 

Warnings

Contraindications

Hypersensitivity to benzonatate and related compounds (tetracaine-type topical anesthetics)

 

Cautions

Keep out of reach of children

Severe hypersensitivity reactions (bronchospasm, cardiovascular collapse) reported with therapy (possibly related to sucking or chewing the capsule)

Deliberate or accidental overdose has resulted in death, particularly in children

Isolated cases of abnormal behavior (mental confusion and visual hallucinations) reported

 

Pregnancy and lactation

Pregnancy category: C

Lactation: Excretion in milk unknown; use caution

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Tessalon, Tessalon Perles (benzonatate)

Mechanism of action

Nonnarcotic antitussive; local anesthetic effect anesthetizes stretch receptors in respiratory passages and lungs

 

Absorption

Onset: 15-20 min

Duration: 3-8 hr